Preferred place of death and end-of-life care for adult cancer patients in Iran: A cross-sectional study.
Iran
cancer
end of life
hospice
palliative care
preferred place of care
preferred place of death
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
04
2022
accepted:
08
07
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
23
8
2022
Statut:
epublish
Résumé
More than 50,000 deaths in terms of cancer occur annually in Iranian hospitals. Determining the preferred place of end-of-life care and death for cancer patients in Iran is a quality marker for good end-of-life care and good death. The purpose of this study was to determine the preferred place of end-of-life care and death in cancer patients. In 2021, the current descriptive cross-sectional investigation was carried out. Using the convenience sample approach, patients were chosen from three Tehran referral hospitals (the capital of Iran). A researcher-made questionnaire with three parts for demographic data, clinical features, and two questions on the choice of the desired location for end-of-life care and the death of cancer patients served as the data collecting instrument. Data were analyzed using SPSS software version 18. The relationship between the two variables preferred place for end-of-life care and death and other variables was investigated using chi-square, Fisher exact test, and multiple logistic regression. The mean age of patients participating in the study was 50.21 ± 13.91. Three hundred ninety (69.6%) of the patients chose home, and 170 (30.4%) patients chose the hospital as the preferred place of end-of-life care. Choosing the home as a preferred place for end-of-life care had a significant relationship with type of care (OR = .613 [95% CI: 0.383-0.982], P = .042), level of education (OR = 2.61 [95% CI: 1.29-5.24], P = 0.007), type of cancer (OR = 1.70 [1.01-2.89], P = .049), and income level ( The findings of the current research indicate that the majority of cancer patients selected their homes as the preferred location for end-of-life care and final disposition. Researchers advise paying more attention to patients' wishes near the end of life in light of the findings of the current study. This will be achieved by strengthening the home care system using creating appropriate infrastructure, insurance coverage, designing executive instructions, and integration of palliative care in home care services.
Sections du résumé
Background
UNASSIGNED
More than 50,000 deaths in terms of cancer occur annually in Iranian hospitals. Determining the preferred place of end-of-life care and death for cancer patients in Iran is a quality marker for good end-of-life care and good death. The purpose of this study was to determine the preferred place of end-of-life care and death in cancer patients.
Method
UNASSIGNED
In 2021, the current descriptive cross-sectional investigation was carried out. Using the convenience sample approach, patients were chosen from three Tehran referral hospitals (the capital of Iran). A researcher-made questionnaire with three parts for demographic data, clinical features, and two questions on the choice of the desired location for end-of-life care and the death of cancer patients served as the data collecting instrument. Data were analyzed using SPSS software version 18. The relationship between the two variables preferred place for end-of-life care and death and other variables was investigated using chi-square, Fisher exact test, and multiple logistic regression.
Result
UNASSIGNED
The mean age of patients participating in the study was 50.21 ± 13.91. Three hundred ninety (69.6%) of the patients chose home, and 170 (30.4%) patients chose the hospital as the preferred place of end-of-life care. Choosing the home as a preferred place for end-of-life care had a significant relationship with type of care (OR = .613 [95% CI: 0.383-0.982], P = .042), level of education (OR = 2.61 [95% CI: 1.29-5.24], P = 0.007), type of cancer (OR = 1.70 [1.01-2.89], P = .049), and income level (
Conclusion
UNASSIGNED
The findings of the current research indicate that the majority of cancer patients selected their homes as the preferred location for end-of-life care and final disposition. Researchers advise paying more attention to patients' wishes near the end of life in light of the findings of the current study. This will be achieved by strengthening the home care system using creating appropriate infrastructure, insurance coverage, designing executive instructions, and integration of palliative care in home care services.
Identifiants
pubmed: 35992820
doi: 10.3389/fonc.2022.911397
pmc: PMC9382894
doi:
Types de publication
Journal Article
Langues
eng
Pagination
911397Informations de copyright
Copyright © 2022 Fereidouni, Salesi, Rassouli, Hosseinzadegan, Javid, Karami, Elahikhah and Barasteh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):845-851
pubmed: 32212816
BMJ. 2015 Oct 07;351:h4855
pubmed: 26446163
Acta Oncol. 2020 Jun;59(6):620-627
pubmed: 32148138
Am J Hosp Palliat Care. 2019 May;36(5):423-428
pubmed: 30477314
J Palliat Med. 2010 Jun;13(6):695-701
pubmed: 20568968
J Pain Symptom Manage. 2019 May;57(5):923-932
pubmed: 30708125
PLoS One. 2013;8(3):e56848
pubmed: 23520458
Front Psychol. 2021 Aug 27;12:704590
pubmed: 34512460
Indian J Palliat Care. 2018 Jan-Mar;24(1):51-57
pubmed: 29440807
Support Care Cancer. 2012 Oct;20(10):2575-82
pubmed: 22270089
Am J Hosp Palliat Care. 2015 Dec;32(8):835-40
pubmed: 25007797
J Hosp Med. 2013 Apr;8(4):178-83
pubmed: 23440934
J Palliat Med. 2017 Nov;20(11):1217-1224
pubmed: 28574737
J Clin Oncol. 2012 Aug 1;30(22):2783-7
pubmed: 22734023
BMC Geriatr. 2017 Nov 23;17(1):271
pubmed: 29169346
Age Ageing. 2021 Nov 10;50(6):2004-2011
pubmed: 34473834
BMJ. 2009 Jul 15;339:b2391
pubmed: 19605422
J Med Genet. 2018 Apr;55(4):222-232
pubmed: 29440349
Asian Pac J Cancer Prev. 2021 Jan 01;22(1):295-300
pubmed: 33507711
J Glob Oncol. 2018 Sep;4:1-9
pubmed: 30241251
Ann Oncol. 2012 Aug;23(8):2006-2015
pubmed: 22345118
Ann Oncol. 1997 Sep;8(9):857-63
pubmed: 9358935
Am J Hosp Palliat Care. 2022 Jul;39(7):762-771
pubmed: 34657488
Can J Aging. 2006 Winter;25(4):363-71
pubmed: 17310457
BMJ. 2006 Mar 4;332(7540):515-21
pubmed: 16467346
PLoS One. 2019 Feb 14;14(2):e0211622
pubmed: 30763320
Support Care Cancer. 2005 Aug;13(8):565-72
pubmed: 15812653
Asia Pac J Oncol Nurs. 2019 Dec 05;7(1):103-112
pubmed: 31879691
BMJ Support Palliat Care. 2021 Mar;11(1):7-16
pubmed: 32393531
Iran J Public Health. 2021 Jan;50(1):35-45
pubmed: 34178762
Palliat Med. 2013 Feb;27(2):155-64
pubmed: 22419677
J Nurs Res. 2014 Mar;22(1):37-44
pubmed: 24517898
BMC Med. 2015 Oct 09;13:235
pubmed: 26449231
J Epidemiol Community Health. 2006 May;60(5):412-6
pubmed: 16614331
Geriatr Gerontol Int. 2010 Apr;10(2):154-60
pubmed: 20446929
Cancer Nurs. 2003 Jun;26(3):245-51
pubmed: 12832958
Am J Hosp Palliat Care. 2014 May;31(3):300-6
pubmed: 23661770